StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)

Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –

Novo Nordisk A S net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for Novo Nordisk A S

Novo Nordisk A S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Novo Nordisk A S figures

See a number that looks wrong?